Harbour Investments’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$58.7K Buy
320
+105
+49% +$19.3K ﹤0.01% 2245
2025
Q4
$37.8K Buy
215
+8
+4% +$1.31K ﹤0.01% 2094
2025
Q3
$29K Buy
207
+6
+3% +$811 ﹤0.01% 2159
2025
Q2
$25.2K Buy
201
+6
+3% +$748 ﹤0.01% 2134
2025
Q1
$26.7K Sell
195
-17
-8% -$2.43K ﹤0.01% 2062
2024
Q4
$32.4K Buy
212
+41
+24% +$6.92K ﹤0.01% 1917
2024
Q3
$33.1K Sell
171
-6
-3% -$1.25K ﹤0.01% 1858
2024
Q2
$41K Buy
177
+15
+9% +$3.26K ﹤0.01% 1651
2024
Q1
$34.9K Sell
162
-5
-3% -$1.17K ﹤0.01% 1701
2023
Q4
$43.2K Buy
167
+107
+178% +$26.3K ﹤0.01% 1519
2023
Q3
$15.4K Buy
60
+17
+40% +$4.55K ﹤0.01% 1868
2023
Q2
$12.2K Buy
43
+10
+30% +$2.98K ﹤0.01% 1954
2023
Q1
$9.18K Sell
33
-23
-41% -$6.36K ﹤0.01% 2038
2022
Q4
$15.5K Sell
56
-53
-49% -$15K ﹤0.01% 1773
2022
Q3
$22K Hold
109
﹤0.01% 1593
2022
Q2
$22K Buy
+109
New +$22.3K ﹤0.01% 1593
2021
Q4
$39K Sell
162
-402
-71% -$103K ﹤0.01% 1369
2021
Q3
$159K Sell
564
-206
-27% -$67.5K 0.01% 1131
2021
Q2
$267K Buy
770
+27
+4% +$8.18K 0.01% 910
2021
Q1
$208K Buy
+743
New +$200K 0.01% 942

Other funds holding BIIB

Harbour Investments's BIIB Position: Q1 2026 in Review

Harbour Investments increased its Biogen (BIIB) stake by 49% in Q1 2026, buying an estimated $19.3K and bringing the position to 320 shares worth $58.7K. The position accounts for ﹤0.01% of the portfolio, ranked #2245.

Harbour Investments first reported a position in BIIB in Q1 2021 and has held it in 20 quarters since. The position peaked at $267K in Q2 2021. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

  • Harbour Investments held 320 shares of Biogen worth $58.7K as of Q1 2026.
  • Harbour Investments bought 105 Biogen shares in Q1 2026, an estimated $19.3K.
  • Biogen made up ﹤0.01% of Harbour Investments's portfolio in Q1 2026, its #2245 holding.
  • Harbour Investments first reported a position in Biogen in Q1 2021 and has held it in 20 quarters since.
  • Harbour Investments's Biogen position peaked at $267K in Q2 2021.
  • 1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on Harbour Investments's 13F filing for Q1 2026, filed 15 May 2026.